原発性肺がんに対するｃｉｓｐｌａｔｉｎ気管支動脈内注入の臨床的検討　　マイトマイシンＣとの比較

DOI Web Site

書誌事項

タイトル別名
  • Clinical comparison of bronchial artery infusion of cisplatin and mitomycin C in primary non-small cell lung cancer.
  • small Cell Lung Cancer
  • マイトマイシンCとの比較

この論文をさがす

抄録

Bronchial artery infusion (BAI) of 25mg of cisplatin was performed in 25 patients with primary non-small cell lung cancer. No severe side effects were observed after the procedure. No patients showed 50% or greater tumor reduction and only 3 patients showed 20% or greater tumor reduction at 2 weeks after BAI. The tumor reduction rate of this group was smaller than that of 47 cases treated with a combination of BAI of mitomycin C and systemic administration of vincristin (p<0.01). These results suggest that the infusion time, dosage and metabolism of cisplatin must be studied further before it can be used as a cytotoxic drug for BAI.

収録刊行物

  • 肺癌

    肺癌 26 (1), 65-71, 1986

    特定非営利活動法人 日本肺癌学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ